Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA).
Submit written comments on the collection of information by October 23, 2000.
Submit written comments on the collection of information to Office of Information and Regulatory Affairs, OMB, New Executive Office Bldg., 725 17th St. NW., rm. 10235, Washington, DC 20503, Attention: Desk Officer for FDA.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Office of Information Resources Management (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1472.End Further Info End Preamble Start Supplemental Information
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
Guidance for Industry on How to Use E-Mail to Submit Information to the Center for Veterinary Medicine
Description: The Center for Veterinary Medicine (CVM), is responsible for developing and administering guidances that explain how to adhere to the electronic records and electronic signatures regulations (21 CFR part 11). The electronic records and electronic signatures regulations provide for the voluntary submission of parts or all of regulatory records in electronic format without an accompanying paper copy. These regulations comply with the Government Paperwork Elimination Act, (GPEA). The GPEA requires Federal agencies by October 21, 2003, to give persons who are required to maintain, submit, or disclose information, the option of doing so electronically when practical, as a substitute for paper.
This guidance document describes the procedures for persons who are sponsors of new animal drugs who wish to file submissions by e-mail. The guidance document instructs those who wish to submit information to CVM by e-mail to first register with them. Registration entails sending a letter to CVM with a sponsor password and the names, phone numbers, and mail and e-mail addresses of a sponsor coordinator and any person who will submit information electronically to CVM. This letter is sent on paper and electronically. Other information collection provisions described in the guidance are the submission of e-mails with the individual passwords of those who submit information electronically and e-mails with any changes to the sponsor's registration. CVM will use all the information submitted to process electronic submissions.
Description of Respondents: The likely respondents for this collection of information are new animal drug sponsors. In the Federal Register of June 29, 2000 (65 FR 40109), FDA announced availability of this guidance as a draft document and requested public comment. In response to this notice, no comments were received on the estimated annual reporting burden. We therefore believe the annual reporting burden estimate of 140 hours should remain unchanged.
|No. of Respondents||Annual Frequency per Response||Total Annual Responses||Hours per Response||Total Hours|
|1 There are no capital costs or operating and maintenance costs associated with this collection of information.|
The estimates in table 1 of this document resulted from discussions with new animal drug sponsors.Start Signature
Dated: September 14, 2000.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 00-24204 Filed 9-20-00; 8:45 am]
BILLING CODE 4160-01-F